This section focuses on the four key subtypes—PKCα, PKCβ, PKCε, and PKCδ—systematically analyzing their double‐edged roles and targeted intervention strategies in conditions such as sensory abnormalities, stroke, and cognitive impairments. This evidence concerns the gene PRKCD and Stroke.